Series B financing
Nuvig Therapeutics Secures $161M Series B Financing to Advance Immunomodulatory Portfolio
Nuvig Therapeutics, Series B financing, immunomodulatory drugs, autoimmune diseases, chronic inflammatory demyelinating polyneuropathy (CIDP), NVG-2089, clinical trials.
Beacon Therapeutics Raises $170 Million to Advance Ocular Gene Therapy
Beacon Therapeutics, ocular gene therapy, J&J, Series B financing, AGTC-501, rare ophthalmology
iOnctura Secures €80 Million in Series B Financing to Advance Rare Eye Cancer Treatment
iOnctura, Series B financing, rare eye cancer, uveal melanoma, roginolisib, cancer treatment
Engrail Therapeutics Secures $157 Million in Mid-Stage Neuroscience Research Funding
Engrail Therapeutics, Mid-stage neuroscience startup, $157 million funding, Generalized anxiety treatment, Mood disorders, Series B financing